Drive Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$560K Sell
4,429
-6
-0.1% -$791 0.1% 166
2026
Q1
$618K Buy
4,435
+74
+2% +$10.4K 0.13% 133
2025
Q4
$535K Buy
4,361
+143
+3% +$17.4K 0.1% 159
2025
Q3
$468K Sell
4,218
-454
-10% -$51.6K 0.1% 175
2025
Q2
$518K Buy
4,672
+1,048
+29% +$112K 0.11% 155
2025
Q1
$406K Buy
3,624
+485
+15% +$50K 0.1% 165
2024
Q4
$290K Buy
+3,139
New +$283K 0.07% 220

Other funds holding GILD

Drive Wealth Management's GILD Position: Q2 2026 in Review

Drive Wealth Management reduced its Gilead Sciences (GILD) stake by 0.14% in Q2 2026, selling an estimated $791 and leaving 4,429 shares worth $560K. The position accounts for 0.1% of the portfolio, ranked #166.

Drive Wealth Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $618K in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Drive Wealth Management held 4,429 shares of Gilead Sciences worth $560K as of Q2 2026.
  • Drive Wealth Management sold 6 Gilead Sciences shares in Q2 2026, an estimated $791.
  • Gilead Sciences made up 0.1% of Drive Wealth Management's portfolio in Q2 2026, its #166 holding.
  • Drive Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Drive Wealth Management's Gilead Sciences position peaked at $618K in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Drive Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.